Back to calendar
Allogene Therapeutics, Inc. (ALLO) Earnings
ALLO reports earnings on Wednesday, August 5, 2026
earnings report
August 5, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.17
Actual EPS: $-0.18
EPS surprise: 5.32%
Company overview
Market Cap$617.8M
PriceUSD 1.79
EPS (TTM)-0.77
52-week high4.46
52-week low0.98
SectorHealth Technology
IndustryBiotechnology
Employees152